Delphi consensus of 73 UTUC experts agrees on 32 of 40 statements for non-metastatic UTUC care
Guideline · Nat Rev Urol · 2026-11-13. Number 2 in the UrologyWatch Top 5 for November 13, 2026.
A two-round, web-based Delphi survey of 73 international UTUC experts (urologists and medical oncologists) rated 40 statements on diagnosis, staging, and treatment of non-metastatic upper tract urothelial carcinoma. Consensus was reached on 32 of 40 statements (80%) across both rounds, offering expert-informed guidance given limited high-level evidence in this disease.
Why it matters: Offers pragmatic expert consensus to help reduce practice variability in non-metastatic UTUC, an area with limited randomized trial evidence, though it is not a formal clinical guideline.
Source: Nat Rev Urol · PubMed 43015446 · DOI 10.1038/s41585-026-01209-9
Loading today's edition…